NCI Registry

National:

NCI National Clinical Trials Network (NCTN) and other NIH-supported National Trial Networks.

Externally Peer-Reviewed:

R01s, SPORES, U01s, U10s, P01s, CTEP, or any other clinical research study mechanism supported by the NIH or organizations on this list: Organizations with Peer Review Funding Systems.

Institutional:

In-house clinical research studies authored or co-authored by Cancer Center investigators and undergoing scientific peer review solely by the Protocol Review and Monitoring System of the Cancer Center. The Cancer Center investigator has primary responsibility for conceptualizing, designing, and implementing the clinical research study and reporting results.

It is acceptable for industry and other entities to provide support (such as drug, device or other funding), but the trial should clearly be the intellectual product of the center investigator.
This category may also include:
- Institutional studies authored and implemented by investigators at another Center in which your Center is participating.
- Multi-Institutional studies authored and implemented by investigators at your Center. (Note: National and externally peer-reviewed studies should be listed with those categories, not as Institutional studies.)

Industrial/Other:

A pharmaceutical company controls the design and implementation of these clinical research studies.